Skip to main content
Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
218.00
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT

Sartorius Stedim Biotech Revenue

Sartorius Stedim Biotech had revenue of 744.60M EUR in the quarter ending March 31, 2025, with 11.65% growth. This brings the company's revenue in the last twelve months to 2.86B, up 5.21% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.

Revenue (ttm)
2.86B EUR
Revenue Growth
+5.21%
P/S Ratio
7.21
Revenue / Employee
288.63K EUR
Employees
9,901
Market Cap
22.26B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.78B4.50M0.16%
Dec 31, 20232.78B-717.20M-20.53%
Dec 31, 20223.49B605.70M20.98%
Dec 31, 20212.89B976.92M51.15%
Dec 31, 20201.91B469.51M32.59%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Sartorius Stedim Biotech News

More News